Premier Anti-Aging Co., Ltd.

TSE:4934.T

719 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Revenue 4,9204,7905,3855,2645,790.8426,351.1076,867.1127,391.6048,015.0127,926.7518,104.399,865.759,048.1868,455.3438,098.3117,210.95,933.037
Cost of Revenue 1,1759231,0901,0702,232.9481,834.5951,445.731,644.5032,047.9251,764.4141,529.0781,941.5311,855.8211,567.9361,429.4411,529.6551,284.647
Gross Profit 3,7453,8674,2954,1943,557.8944,516.5125,421.3825,747.1015,967.0876,162.3376,575.3127,924.2197,192.3656,887.4076,668.875,681.2454,648.39
Gross Profit Ratio 0.7610.8070.7980.7970.6140.7110.7890.7780.7440.7770.8110.8030.7950.8150.8230.7880.783
Reseach & Development Expenses 131151103110212.477146.494102.65127.804122.051115.466114.52280.17993.13950.524000
General & Administrative Expenses 0000-4,598.353000-7,531.792000-5,964.7810000
Selling & Marketing Expenses 00008,59800012,92000012,8120000
SG&A 3,6083,5084,3614,1203,999.6474,436.5044,965.4045,863.5915,388.2086,337.7596,287.2095,769.2426,847.2194,859.033000
Other Expenses 3,60852-42.37114.5662.8822.635-25.29321.6164.089-0.723-12.2590.082-2.954-17.293-2.091
Operating Expenses 3,6083,6594,4644,2304,212.1244,582.9985,068.0545,991.3955,510.2596,453.2256,401.7315,849.4216,940.3584,921.2445,095.264,792.9483,825.214
Operating Income 136208-169-35-654.228-66.487353.328-244.294456.828-290.889173.5822,074.797252.0081,966.1621,573.61888.296823.175
Operating Income Ratio 0.0280.043-0.031-0.007-0.113-0.010.051-0.0330.057-0.0370.0210.210.0280.2330.1940.1230.139
Total Other Income Expenses Net -17436-9139-48.70414.697-33.2319.433-26.134110.61516.1257.407-15.324-3.82214.406-22.272-7.382
Income Before Tax -38244-1,082-26-702.932-51.79320.098-224.861430.694-180.274189.7022,132.204236.6841,962.341,588.016866.024815.793
Income Before Tax Ratio -0.0080.051-0.201-0.005-0.121-0.0080.047-0.030.054-0.0230.0230.2160.0260.2320.1960.120.138
Income Tax Expense -485689-122.2475.478148.071-26.821228.679-42.272149.707811.79270.807707.646565.741315.242251.952
Net Income -33235-1,650-35-580.694-127.267172.026-198.039202.016-138.00339.9951,320.414-34.1241,254.6941,022.276550.781563.842
Net Income Ratio -0.0070.049-0.306-0.007-0.1-0.020.025-0.0270.025-0.0170.0050.134-0.0040.1480.1260.0760.095
EPS -3.7826.95-189.21-4.01-66.59-14.5919.73-22.7123.17-15.824.58151.43-3.91145.34119.2968.5264.81
EPS Diluted -3.7826.95-189.21-4.01-66.59-14.5919.73-22.7123.14-15.84.58151.19-3.91145.12119.2868.2564.81
EBITDA -32282-130-21-648.329-45.953323.624-221.778433.899-177.34194.1292,100.824240.0041,966.2651,590.701871.012821.083
EBITDA Ratio -0.0070.059-0.024-0.004-0.112-0.0070.047-0.030.054-0.0220.0240.2130.0270.2330.1960.1210.138